Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad
Objective To evaluate the potential economic benefits of keeping a meningitis A vaccine at or near ambient temperature for up to 4 days during a mass vaccination campaign. Methods During a 10-day mass vaccination campaign against meningitis A in three regions of Chad in 2011, the costs associated...
Main Authors: | Patrick Lydon, Simona Zipursky, Carole Tevi-Benissan, Mamoudou Harouna Djingarey, Placide Gbedonou, Brahim Oumar Youssouf, Michel Zaffran |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2014-02-01
|
Series: | Bulletin of the World Health Organization |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862014000200086&lng=en&tlng=en |
Similar Items
-
Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010.
by: Sung Hye Kim, et al.
Published: (2012-01-01) -
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
by: Daugla, D, et al.
Published: (2013) -
The future of meningitis vaccines.
by: Segal, S, et al.
Published: (2003) -
Vaccines against bacterial meningitis
by: Segal, S, et al.
Published: (2004) -
Vaccines against bacterial meningitis.
by: Segal, S, et al.
Published: (2004)